Characteristics and risk factors for mortality in critically ill patients with COVID-19 receiving invasive mechanical ventilation: the experience of a private network in Sao Paulo, Brazil

1Wang Y, Lu X, Li Y, Chen H, Chen T, Su N, et al. Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19. Am J Respir Crit Care Med 2020;201(11):1430-4. Wang Y Lu X Li Y Chen H Chen T Su N et al Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19 Am J Respir Crit Care Med 2020201 11 1430 410.1164/rccm.202003-0736LESearch in Google Scholar

2Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323(20):2052-9. Richardson S Hirsch JS Narasimhan M Crawford JM McGinn T Davidson KW et al Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area JAMA 2020323 20 2052 910.1001/jama.2020.6775Search in Google Scholar

3Fernandes FT, de Oliveira TA, Teixeira CE, Batista AFM, Dalla Costa G, Chiavegatto Filho ADP. A multipurpose machine learning approach to predict COVID-19 negative prognosis in Sao Paulo, Brazil. Sci Rep 2021;11(1):3343. Fernandes FT de Oliveira TA Teixeira CE Batista AFM Dalla Costa G Chiavegatto Filho ADP A multipurpose machine learning approach to predict COVID-19 negative prognosis in Sao Paulo, Brazil Sci Rep 202111 1 334310.1038/s41598-021-82885-ySearch in Google Scholar

4Kar S, Chawla R, Haranath SP, Ramasubban S, Ramakrishnan N, Vaishya R, et al. Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID). Sci Rep 2021;11(1):12801. Kar S Chawla R Haranath SP Ramasubban S Ramakrishnan N Vaishya R et al Multivariable mortality risk prediction using machine learning for COVID-19 patients at admission (AICOVID) Sci Rep 202111 1 1280110.1038/s41598-021-92146-7Search in Google Scholar

5Group RC, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med 2021;384(8):693-704. Group RC Horby P Lim WS Emberson JR Mafham M Bell JL et al Dexamethasone in Hospitalized Patients with Covid-19 N Engl J Med 2021384 8 693 70410.1056/NEJMoa2021436Search in Google Scholar

6Cavalcanti AB, Zampieri FG, Rosa RG, Azevedo LCP, Veiga VC, Avezum A, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med 2020;383(21):2041-52. Cavalcanti AB Zampieri FG Rosa RG Azevedo LCP Veiga VC Avezum A et al Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 N Engl J Med 2020383 21 2041 5210.1056/NEJMoa2019014Search in Google Scholar

7Zanella A, Florio G, Antonelli M, Bellani G, Berselli A, Bove T, et al. Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units. Intensive Care Med 2021;47(9):995-1008. Zanella A Florio G Antonelli M Bellani G Berselli A Bove T et al Time course of risk factors associated with mortality of 1260 critically ill patients with COVID-19 admitted to 24 Italian intensive care units Intensive Care Med 202147 9 995 1008Search in Google Scholar

8Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Intern Med 2020;180(10):1345-55. Grasselli G Greco M Zanella A Albano G Antonelli M Bellani G et al Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy JAMA Intern Med 2020180 10 1345 5510.1001/jamainternmed.2020.3539Search in Google Scholar

9Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. medRxiv 2020. Cummings MJ Baldwin MR Abrams D Jacobson SD Meyer BJ Balough EM et al Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study medRxiv 202010.1016/S0140-6736(20)31189-2Search in Google Scholar

10Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020;8(9):853-62. Karagiannidis C Mostert C Hentschker C Voshaar T Malzahn J Schillinger G et al Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study Lancet Respir Med 20208 9 853 6210.1016/S2213-2600(20)30316-7Search in Google Scholar

11Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia 2020;75(10):1340-9. Armstrong RA Kane AD Cook TM Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies Anaesthesia 202075 10 1340 910.1111/anae.1520132602561Search in Google Scholar

12Auld SC, Caridi-Scheible M, Blum JM, Robichaux C, Kraft C, Jacob JT, et al. ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med 2020;48(9):e799-e804. Auld SC Caridi-Scheible M Blum JM Robichaux C Kraft C Jacob JT et al ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019 Crit Care Med 202048 9 e799 e80410.1097/CCM.0000000000004457Search in Google Scholar

13Dana R, Bannay A, Bourst P, Ziegler C, Losser MR, Gibot S, et al. Obesity and mortality in critically ill COVID-19 patients with respiratory failure. Int J Obes (Lond) 2021;45(9):2028-37. Dana R Bannay A Bourst P Ziegler C Losser MR Gibot S et al Obesity and mortality in critically ill COVID-19 patients with respiratory failure Int J Obes (Lond) 202145 9 2028 3710.1038/s41366-021-00872-9Search in Google Scholar

14Schavemaker R, Schultz MJ, Lagrand WK, van Slobbe-Bijlsma ER, Serpa Neto A, Paulus F, et al. Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study. J Clin Med 2021;10(6). Schavemaker R Schultz MJ Lagrand WK van Slobbe-Bijlsma ER Serpa Neto A Paulus F et al Associations of Body Mass Index with Ventilation Management and Clinical Outcomes in Invasively Ventilated Patients with ARDS Related to COVID-19-Insights from the PRoVENT-COVID Study J Clin Med 202110 610.3390/jcm10061176Search in Google Scholar

15Azoulay E, Fartoukh M, Darmon M, Geri G, Voiriot G, Dupont T, et al. Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset. Intensive Care Med 2020;46(9):1714-22. Azoulay E Fartoukh M Darmon M Geri G Voiriot G Dupont T et al Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset Intensive Care Med 202046 9 1714 2210.1007/s00134-020-06202-3Search in Google Scholar

16Di Fusco M, Shea KM, Lin J, Nguyen JL, Angulo FJ, Benigno M, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ 2021;24(1):308-17. Di Fusco M Shea KM Lin J Nguyen JL Angulo FJ Benigno M et al Health outcomes and economic burden of hospitalized COVID-19 patients in the United States J Med Econ 202124 1 308 1710.1080/13696998.2021.1886109Search in Google Scholar

17Zangrillo A, Beretta L, Scandroglio AM, Monti G, Fominskiy E, Colombo S, et al. Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy. Crit Care Resusc 2020. Zangrillo A Beretta L Scandroglio AM Monti G Fominskiy E Colombo S et al Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy Crit Care Resusc 2020Search in Google Scholar

18Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA 2020;323(16):1612-4. Arentz M Yim E Klaff L Lokhandwala S Riedo FX Chong M et al Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State JAMA 2020323 16 1612 410.1001/jama.2020.4326Search in Google Scholar

19Argenziano MG, Bruce SL, Slater CL, Tiao JR, Baldwin MR, Barr RG, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ 2020;369:m1996. Argenziano MG Bruce SL Slater CL Tiao JR Baldwin MR Barr RG et al Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series BMJ 2020369m199610.1136/bmj.m1996Search in Google Scholar

20Qian Z, Alaa AM, van der Schaar M, Ercole A. Between-centre differences for COVID-19 ICU mortality from early data in England. Intensive Care Med 2020;46(9):1779-80. Qian Z Alaa AM van der Schaar M Ercole A Between-centre differences for COVID-19 ICU mortality from early data in England Intensive Care Med 202046 9 1779 8010.1007/s00134-020-06150-ySearch in Google Scholar

21Ranzani OT, Bastos LSL, Gelli JGM, Marchesi JF, Baiao F, Hamacher S, et al. Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data. Lancet Respir Med 2021;9(4):407-18. Ranzani OT Bastos LSL Gelli JGM Marchesi JF Baiao F Hamacher S et al Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data Lancet Respir Med 20219 4 407 1810.1016/S2213-2600(20)30560-9Search in Google Scholar

22Gupta S, Hayek SS, Wang W, Chan L, Mathews KS, Melamed ML, et al. Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US. JAMA Intern Med 2020;180(11):1436-47. Gupta S Hayek SS Wang W Chan L Mathews KS Melamed ML et al Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US JAMA Intern Med 2020180 11 1436 4710.1001/jamainternmed.2020.3596736433832667668Search in Google Scholar

23Millar JE, Busse R, Fraser JF, Karagiannidis C, McAuley DF. Apples and oranges: international comparisons of COVID-19 observational studies in ICUs. Lancet Respir Med 2020;8(10):952-3. Millar JE Busse R Fraser JF Karagiannidis C McAuley DF Apples and oranges: international comparisons of COVID-19 observational studies in ICUs Lancet Respir Med 20208 10 952 310.1016/S2213-2600(20)30368-4Search in Google Scholar

24Network C-IGobotR, the C-ICUI. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med 2021;47(1):60-73. Network C-IGobotR, the C-ICUI Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study Intensive Care Med 202147 1 60 7310.1007/s00134-020-06294-x767457533211135Search in Google Scholar

25Schenck EJ, Hoffman K, Goyal P, Choi J, Torres L, Rajwani K, et al. Respiratory Mechanics and Gas Exchange in COVID-19-associated Respiratory Failure. Ann Am Thorac Soc 2020;17(9):1158-61. Schenck EJ Hoffman K Goyal P Choi J Torres L Rajwani K et al Respiratory Mechanics and Gas Exchange in COVID-19-associated Respiratory Failure Ann Am Thorac Soc 202017 9 1158 6110.1513/AnnalsATS.202005-427RL746232332432896Search in Google Scholar

26Lotz C, Muellenbach RM, Meybohm P, Mutlak H, Lepper PM, Rolfes CB, et al. Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile? Acta Anaesthesiol Scand 2021;65(5):629-32. Lotz C Muellenbach RM Meybohm P Mutlak H Lepper PM Rolfes CB et al Effects of inhaled nitric oxide in COVID-19-induced ARDS - Is it worthwhile? Acta Anaesthesiol Scand 202165 5 629 3210.1111/aas.1375733296498Search in Google Scholar

27Man Niu M, Cao Y, Li RX, Fan GZ, Hu P. Outcome heterogeneity in COVID-19 patients receiving tocilizumab. Clin Infect Dis 2021. Man Niu M Cao Y Li RX Fan GZ Hu P Outcome heterogeneity in COVID-19 patients receiving tocilizumab Clin Infect Dis 2021Search in Google Scholar

28Malgie J, Schoones JW, Pijls BG. Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies. Clin Infect Dis 2021;72(11):e742-e9. Malgie J Schoones JW Pijls BG Decreased Mortality in Coronavirus Disease 2019 Patients Treated With Tocilizumab: A Rapid Systematic Review and Meta-analysis of Observational Studies Clin Infect Dis 202172 11 e742 e910.1093/cid/ciaa1445754335032964913Search in Google Scholar

29Investigators R-C, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, Nichol AD, et al. Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. N Engl J Med 2021;384(16):1491-502. Investigators R-C Gordon AC Mouncey PR Al-Beidh F Rowan KM Nichol AD et al Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 N Engl J Med 2021384 16 1491 50210.1056/NEJMoa2100433795346133631065Search in Google Scholar

30Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care 2021;11(1):123. Lumlertgul N Pirondini L Cooney E Kok W Gregson J Camporota L et al Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study Ann Intensive Care 202111 1 12310.1186/s13613-021-00914-5834334234357478Search in Google Scholar

31Hirsch JS, Ng JH, Ross DW, Sharma P, Shah HH, Barnett RL, et al. Acute kidney injury in patients hospitalized with COVID-19. Kidney Int 2020;98(1):209-18. Hirsch JS Ng JH Ross DW Sharma P Shah HH Barnett RL et al Acute kidney injury in patients hospitalized with COVID-19 Kidney Int 202098 1 209 1810.1016/j.kint.2020.05.006722946332416116Search in Google Scholar

32Bowe B, Cai M, Xie Y, Gibson AK, Maddukuri G, Al-Aly Z. Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19. Clin J Am Soc Nephrol 2020;16(1):14-25. Bowe B Cai M Xie Y Gibson AK Maddukuri G Al-Aly Z Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19 Clin J Am Soc Nephrol 202016 1 14 2510.2215/CJN.09610620779264333199414Search in Google Scholar

33Gazivoda VP, Ibrahim M, Kangas-Dick A, Sun A, Silver M, Wiesel O. Outcomes of Barotrauma in Critically Ill COVID-19 Patients With Severe Pneumonia. J Intensive Care Med 2021;36(10):1176-83. Gazivoda VP Ibrahim M Kangas-Dick A Sun A Silver M Wiesel O Outcomes of Barotrauma in Critically Ill COVID-19 Patients With Severe Pneumonia J Intensive Care Med 202136 10 1176 8310.1177/08850666211023360822125034151633Search in Google Scholar

34Chong WH, Saha BK, Hu K, Chopra A. The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review. Heart Lung 2021;50(5):599-608. Chong WH Saha BK Hu K Chopra A The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review Heart Lung 202150 5 599 60810.1016/j.hrtlng.2021.04.005808823534087677Search in Google Scholar

35Chopra A, Al-Tarbsheh AH, Shah NJ, Yaqoob H, Hu K, Feustel PJ, et al. Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study. Respir Med 2021;184:106464. Chopra A Al-Tarbsheh AH Shah NJ Yaqoob H Hu K Feustel PJ et al Pneumothorax in critically ill patients with COVID-19 infection: Incidence, clinical characteristics and outcomes in a case control multicenter study Respir Med 202118410646410.1016/j.rmed.2021.106464811612734044224Search in Google Scholar

36Belletti A, Landoni G, Zangrillo A. Pneumothorax and barotrauma in invasively ventilated patients with COVID-19. Respir Med 2021;187:106552. Belletti A Landoni G Zangrillo A Pneumothorax and barotrauma in invasively ventilated patients with COVID-19 Respir Med 202118710655210.1016/j.rmed.2021.106552832351434364198Search in Google Scholar

37Parker JC, Hernandez LA, Peevy KJ. Mechanisms of ventilator-induced lung injury. Crit Care Med 1993;21(1):131-43. Parker JC Hernandez LA Peevy KJ Mechanisms of ventilator-induced lung injury Crit Care Med 199321 1 131 4310.1097/00003246-199301000-000248420720Search in Google Scholar

38Udi J, Lang CN, Zotzmann V, Krueger K, Fluegler A, Bamberg F, et al. Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation- A Case-Control Study. J Intensive Care Med 2021;36(4):477-83. Udi J Lang CN Zotzmann V Krueger K Fluegler A Bamberg F et al Incidence of Barotrauma in Patients With COVID-19 Pneumonia During Prolonged Invasive Mechanical Ventilation- A Case-Control Study J Intensive Care Med 202136 4 477 8310.1177/088506662095436432959730Search in Google Scholar

39Roden AC, Bois MC, Johnson TF, Aubry MC, Alexander MP, Hagen CE, et al. The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection. Arch Pathol Lab Med 2021;145(1):11-21. Roden AC Bois MC Johnson TF Aubry MC Alexander MP Hagen CE et al The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection Arch Pathol Lab Med 2021145 1 11 2110.5858/arpa.2020-0491-SA32821902Search in Google Scholar

40Fahmy OH, Daas FM, Salunkhe V, Petrey JL, Cosar EF, Ramirez J, et al. Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings. Crit Care Explor 2021;3(5):e0427. Fahmy OH Daas FM Salunkhe V Petrey JL Cosar EF Ramirez J et al Is Microthrombosis the Main Pathology in Coronavirus Disease 2019 Severity?-A Systematic Review of the Postmortem Pathologic Findings Crit Care Explor 20213 5 e042710.1097/CCE.0000000000000427814077634036278Search in Google Scholar

41McGuinness G, Zhan C, Rosenberg N, Azour L, Wickstrom M, Mason DM, et al. Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation. Radiology 2020;297(2):E252-E62. McGuinness G Zhan C Rosenberg N Azour L Wickstrom M Mason DM et al Increased Incidence of Barotrauma in Patients with COVID-19 on Invasive Mechanical Ventilation Radiology 2020297 2 E252 E6210.1148/radiol.2020202352733675132614258Search in Google Scholar

42Hillman K. Barotrauma and COVID-19. Intensive Care Med 2022;48(3):376. Hillman K Barotrauma and COVID-19 Intensive Care Med 202248 3 37610.1007/s00134-022-06630-3879534535089408Search in Google Scholar

43Mehta AB, Douglas IS, Walkey AJ. Evidence-based Utilization of Noninvasive Ventilation and Patient Outcomes. Ann Am Thorac Soc 2017;14(11):1667-73. Mehta AB Douglas IS Walkey AJ Evidence-based Utilization of Noninvasive Ventilation and Patient Outcomes Ann Am Thorac Soc 201714 11 1667 7310.1513/AnnalsATS.201703-208OC571128128541747Search in Google Scholar

44Wunsch H. Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology. Am J Respir Crit Care Med 2020;202(1):1-4. Wunsch H Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology Am J Respir Crit Care Med 2020202 1 1 410.1164/rccm.202004-1385ED732830832402207Search in Google Scholar